The ExpiCHO™ transient expression system offers a turnkey solution for generating high-titer recombinant proteins for therapeutic drug development, reagent generation, as well as an alternative platform for proteins that express poorly in 293-based systems. Because of the significant unmet need for high titer transient CHO protein production, the ExpiCHO system has become a key part of the transient expression workflow in many companies around the world. In this presentation, we will share with researchers the latest data on the ExpiCHO expression system, tips to help optimize the system for maximal performance and protocols to allow for scalable protein expression from the micro to the macro scale.
Cancer Research
Biotechnology
Cell Biology
Molecular Biology
Clinical Research
Immunology
Antibodies
Infectious Disease
Laboratory Testing
Cell Culture
Cancer Therapeutics
Biochemistry
Drug Discovery
Crispr-Cas9
Microbiology
North America51%
Asia23%
South America13%
Europe10%
Africa3%
Website Visitors100%
Scientist20%
Student20%
Research Scientist18%
Educator/Faculty8%
Facility/Department Manager7%
Executive7%
Post Doc5%
Microbiologist3%
Medical Doctor/Specialist3%
Marketing/Sales3%
Biologist2%
Animal Care Lab Technician2%
Medical Laboratory Technician2%
Biotech Company14%
Academic Institution12%
Life Science Company6%
Research Institute4%
Pharmaceutical Company4%
Clinical Laboratory1%
Association1%
Consultant1%
Ambulatory Care1%
Government1%
Hospital1%
Manufacturer - Other1%
Other4%